ITRMF · Iterum Therapeutics plc · Investor Relations
$0.03
+0.01 (+34.78%)
At close · Jul 21
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Going-concern doubt
— flagged Nov 14, 2025
Substantial doubt about the company's ability to continue as a going concern.
“This condition raises substantial doubt about the Company's ability to continue as a going concern for one year from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Nov 14, 2025
Market Cap
$446
Shares
44.66M
Volume · Jul 21
18.8K
Avg daily vol (3M)
99.9K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-18 | Extraordinary General Meeting of Shareholders | Shareholder meeting |
Source: https://ir.iterumtx.com/